“FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES”. 2026. ISIR Journal of Business and Management Studies (ISIRJBMS) 3 (5): 45-55. https://isirpublisher.com/index.php/isirjbms/article/view/48.